ClassID:

95301

C07D417/12 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#301
20240368109
2024-11-07

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#302
20240368096
2024-11-07

Fused Heterobicyclic Antiviral Agents

#303
20240368091
2024-11-07

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

#304
20240360120
2024-10-31

RAD51 INHIBITORS

#305
20240360119
2024-10-31

SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS

#306
20240360100
2024-10-31

HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS

#307
20240360085
2024-10-31

Glucose Uptake Inhibitors

#308
20240360083
2024-10-31

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#309
20240360082
2024-10-31

SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS

#310
20240352010
2024-10-24

SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

#311
20240351997
2024-10-24

NOVEL PARP7 INHIBITOR AND USE THEREOF

#312
20240351987
2024-10-24

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS

#313
20240350468
2024-10-24

MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF

#314
20240349726
2024-10-24

SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

#315
20240343723
2024-10-17

CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

#316
20240343709
2024-10-17

SUBSTITUTED HETEROCYCLES AS ALDEHYDE DEHYDROGENASE INHIBITORS

#317
20240343706
2024-10-17

PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF

#318
20240343694
2024-10-17

PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

#319
20240336608
2024-10-10

IL4I1 INHIBITORS AND METHODS OF USE

#320
20240336602
2024-10-10

Heterocycle derivatives for treating TRPM3 mediated disorders

#321
20240336582
2024-10-10

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

#322
20240336574
2024-10-10

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#323
20240336570
2024-10-10

Modulators of mas-related g-protein receptor X2 and related products and methods

#324
20240335427
2024-10-10

SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)

#325
20240327707
2024-10-03

HETEROARYL-THIO-SUBSTITUTED PYRONES

#326
20240327398
2024-10-03

Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions

#327
20240327334
2024-10-03

Covalent Inhibitors As Antiviral Agents

#328
20240317767
2024-09-26

PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS

#329
20240317733
2024-09-26

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#330
20240317732
2024-09-26

A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13

#331
20240317729
2024-09-26

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

#332
20240317718
2024-09-26

SUBSTITUTED HETEROCYCLIC COMPOUNDS

#333
20240317708
2024-09-26

INHIBITORS OF TRANSGLUTAMINASES

#334
20240316034
2024-09-26

Chemokine CXCR4 Receptor Modulators and Uses Related Thereto

#335
20240316021
2024-09-26

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

#336
20240316017
2024-09-26

NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

#337
20240308965
2024-09-19

1,3-SUBSTITUTED CYCLOBUTYL DERIVATIVES AND USES THEREOF

#338
20240300939
2024-09-12

UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER

#339
20240300909
2024-09-12

2-aminothiazoles derivatives and method of preparation thereof using super-paramagnetic iron oxide nanoparticles (SPIONs)

#340
20240300892
2024-09-12

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#341
20240299385
2024-09-12

3-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS

#342
20240298529
2024-09-05

Arylamine compound, organic electroluminescent device, and electronic apparatus

#343
20240294481
2024-09-05

Drp-1 inhibitors as therapeutic agents

#344
20240294480
2024-09-05

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

#345
20240293386
2024-09-05

NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR

#346
20240292840
2024-09-05

TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS

#347
20240287098
2024-08-29

COMPOSITIONS AND METHODS FOR TREATING CANCER

#348
20240287080
2024-08-29

O-LINKED THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORS

#349
20240287058
2024-08-29

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#350
20240285808
2024-08-29

MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES

#351
20240279220
2024-08-22

INDOLE COMPOUNDS AND METHODS OF USE

#352
20240279209
2024-08-22

Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins

#353
20240279201
2024-08-22

DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE

#354
20240279174
2024-08-22

ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#355
20240277723
2024-08-22

Aryl-or heteroaryl-substituted benzene compounds

#356
20240277701
2024-08-22

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

#357
20240270738
2024-08-15

UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS

#358
20240270737
2024-08-15

SMALL MOLECULAR INHIBITORS OF STING SIGNALING COMPOSITIONS AND METHODS OF USE

#359
20240270736
2024-08-15

MACROCYCLIC HETEROCYCLES AND USES THEREOF

#360
20240270717
2024-08-15

COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS

#361
20240269113
2024-08-15

3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES

#362
20240262817
2024-08-08

QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2

#363
20240262816
2024-08-08

METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE BY HYDROGENATION OF THE 2-OXO DERIVATIVE IN THE PRESENCE OF A CHIRAL TRANSITION METAL CATALYST

#364
20240262812
2024-08-08

N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF

#365
20240262801
2024-08-08

COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES

#366
20240262796
2024-08-08

SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE

#367
20240254116
2024-08-01

BENZOTHIAZINONE DERIVATIVE SUBSTITUTED WITH TRIFLUOROMETHYL AT 6-POSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#368
20240254110
2024-08-01

FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1

#369
20240254109
2024-08-01

SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

#370
20240254096
2024-08-01

ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS

#371
20240254089
2024-08-01

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

#372
20240254086
2024-08-01

(HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT

#373
20240246950
2024-07-25

Anilino-Pyrazole Derivatives, Compositions and Methods Thereof

#374
20240246949
2024-07-25

SOLID STATE FORMS OF LANIFIBRANOR AND PROCESS FOR PREPARATION THEREOF

#375
20240246932
2024-07-25

ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS

#376
20240246931
2024-07-25

COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF

#377
20240246909
2024-07-25

EBNA1 Inhibitors and Methods Using Same

#378
20240245698
2024-07-25

Aryl-OR heteroaryl-substituted benzene compounds

#379
20240245697
2024-07-25

Aryl-or heteroaryl-substituted benzene compounds

#380
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#381
20240239787
2024-07-18

COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

#382
20240239766
2024-07-18

3-AMINO PIPERIDYL SODIUM CHANNEL INHIBITORS

#383
20240239760
2024-07-18

PPARG INVERSE AGONISTS AND USES THEREOF

#384
20240239759
2024-07-18

ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS

#385
20240239752
2024-07-18

BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5

#386
20240238258
2024-07-18

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

#387
20240228476
2024-07-11

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

#388
20240228460
2024-07-11

PROTEASE INHIBITORS AND METHODS OF MAKING SAME

#389
20240228446
2024-07-11

PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT

#390
20240226106
2024-07-11

INHIBITORS OF PLASMA KALLIKREIN

#391
20240226098
2024-07-11

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#392
20240217968
2024-07-04

PHARMACEUTICAL COMPOUND

#393
20240208971
2024-06-27

INHIBITORS OF KINASE NETWORKS AND USES THEREOF

#394
20240208960
2024-06-27

AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS

#395
20240208959
2024-06-27

THIAZOLE/ISOTHIAZOLE HSD17B13 INHIBITORS AND USES THEREOF

#396
20240208927
2024-06-27

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#397
20240208909
2024-06-27

SUBSTITUTED QUINOLINE DERIVATIVES HAVING SOS1 INHIBITION ACTIVITIES AND USES THEREOF

#398
20240199640
2024-06-20

NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#399
20240199596
2024-06-20

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

#400
20240199591
2024-06-20

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

#401
20240199572
2024-06-20

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA

#402
20240199546
2024-06-20

INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF

#403
20240199542
2024-06-20

SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

#404
20240190855
2024-06-13

CDK INHIBITORS AND METHODS OF USE THEREOF

#405
20240190844
2024-06-13

PYRIDAZINONES AS PARP7 INHIBITORS

#406
20240190824
2024-06-13

INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION

#407
20240190810
2024-06-13

COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME

#408
20240180922
2024-06-06

TREATMENTS FOR DIABETIC NEUROPATHY

#409
20240180886
2024-06-06

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

#410
20240174685
2024-05-30

OX2R Compounds

#411
20240174679
2024-05-30

HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#412
20240174660
2024-05-30

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#413
20240174636
2024-05-30

NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#414
20240174634
2024-05-30

Aldehyde Dehydrogenase Inhibitors and Their Therapeutic Use

#415
20240174625
2024-05-30

COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES

#416
20240174605
2024-05-30

ARYLSULFONAMIDES AS OREXIN RECEPTOR AGONISTS

#417
20240166598
2024-05-23

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME

#418
20240158414
2024-05-16

BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

#419
20240158375
2024-05-16

COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS

#420
20240158356
2024-05-16

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#421
20240158338
2024-05-16

COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME

#422
20240150376
2024-05-09

Compounds, Compositions and Methods

#423
20240150374
2024-05-09

Lysine acetyltransferase 6A (KAT6A) inhibitors and uses thereof

#424
20240150297
2024-05-09

NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES

#425
20240150296
2024-05-09

Human plasma kallikrein inhibitors

#426
20240150295
2024-05-09

Human plasma kallikrein inhibitors

#427
20240150284
2024-05-09

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

#428
20240140929
2024-05-02

HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF

#429
20240140922
2024-05-02

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

#430
20240139194
2024-05-02

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

#431
20240139152
2024-05-02

HBV INHIBITOR AND ITS USE

#432
20240132486
2024-04-25

RNF4 TARGETING COMPOUNDS AND USES THEREOF

#433
20240132485
2024-04-25

HETEROCYCLIC CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF

#434
20240132480
2024-04-25

INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE

#435
20240132469
2024-04-25

Substituted heterocycles as aldehyde dehydrogenase inhibitors

#436
20240132458
2024-04-25

NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE

#437
20240132455
2024-04-25

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#438
20240124449
2024-04-18

Compounds and methods for inhibiting fascin

#439
20240124437
2024-04-18

INJECTABLE LURASIDONE SUSPENSION AND PREPARATION METHOD THEREFOR

#440
20240124413
2024-04-18

COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS

#441
20240116916
2024-04-11

METHOD FOR PREPARING AN ENANTIOMERICALLY ENRICHED FORM OF 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE

#442
20240116910
2024-04-11

Heterocycles as WIP1 Inhibitors

#443
20240116902
2024-04-11

ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

#444
20240116897
2024-04-11

BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

#445
20240116885
2024-04-11

BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE

#446
20240116872
2024-04-11

PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING

#447
20240116871
2024-04-11

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

#448
20240114908
2024-04-11

2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT

#449
20240109880
2024-04-04

LYSINE ACETYLTRANSFERASE 6A (KAT6A) INHIBITORS AND USES THEREOF

#450
20240109862
2024-04-04

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#451
20240109853
2024-04-04

ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE

#452
20240109842
2024-04-04

ACRYLAMIDE COMPOUNDS

#453
20240101548
2024-03-28

HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#454
20240101547
2024-03-28

METHOD FOR PREPARING 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-OXO-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE

#455
20240101546
2024-03-28

HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

#456
20240101542
2024-03-28

ERAP INHIBITORS

#457
20240101539
2024-03-28

Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins

#458
20240092802
2024-03-21

MU-OPIOID RECEPTOR AGONISTS AND USES THEREFOR

#459
20240092788
2024-03-21

MASP-2 INHIBITORS AND METHODS OF USE

#460
20240092773
2024-03-21

DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES

#461
20240092771
2024-03-21

CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

#462
20240092770
2024-03-21

Heterocycle RMB39 Modulators

#463
20240092769
2024-03-21

(CYANO-DIMETHYL-METHYL)-ISOXAZOLES AND -[1,3,4]THIADIAZOLES

#464
20240091205
2024-03-21

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

#465
20240083872
2024-03-14

CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY

#466
20240083871
2024-03-14

DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#467
20240083857
2024-03-14

2-Methyl-Quinazolines

#468
20240083854
2024-03-14

TEAD INHIBITORS AND USES THEREOF

#469
20240076291
2024-03-07

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#470
20240067656
2024-02-29

Compositions and methods for treating cancer

#471
20240067610
2024-02-29

Inhibitors of NLRP3 inflammasome

#472
20240059686
2024-02-22

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR

#473
20240059681
2024-02-22

NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF

#474
20240059659
2024-02-22

INHIBITORS OF NLRP3 INFLAMMASOME

#475
20240051952
2024-02-15

HMOX1 inducers

#476
20240051949
2024-02-15

HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

#477
20240051948
2024-02-15

ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE

#478
20240051945
2024-02-15

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

#479
20240051923
2024-02-15

INHIBITORS OF NLRP3 INFLAMMASOME

#480
20240043395
2024-02-08

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#481
20240043393
2024-02-08

cGAS antagonist compounds

#482
20240043384
2024-02-08

INHIBITORS OF PU.1 FOR THE TREATMENT OF DISEASE

#483
20240025890
2024-01-25

HEPATITIS B CORE PROTEIN MODULATORS

#484
20240025880
2024-01-25

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#485
20240025862
2024-01-25

SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES

#486
20240025849
2024-01-25

INHIBITORS OF NO PRODUCTION

#487
20240018135
2024-01-18

COMPOUND HAVING INHIBITORY ACTIVITY AGAINST O-GLUSACASE AND USE THEREOF

#488
20240018133
2024-01-18

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#489
20240018120
2024-01-18

MAGL INHIBITORS

#490
20240018119
2024-01-18

CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS

#491
20240010645
2024-01-11

Aminothiazole Compounds as Inhibitors of CTPS1

#492
20240010642
2024-01-11

MODULATORS OF PROGRAMMED DEATH-LIGAND-1

#493
20240010641
2024-01-11

N-Linked Glycosylation Inhibitors and Methods of Using Same

#494
20240002374
2024-01-04

5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

#495
20240002360
2024-01-04

BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR

#496
20230416211
2023-12-28

Compounds and compositions for treating conditions associated with NLRP activity

#497
20230416205
2023-12-28

COMPOUNDS, COMPOSITIONS, AND METHODS

#498
20230414775
2023-12-28

TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES

#499
20230407285
2023-12-21

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

#500
20230406848
2023-12-21

Compound and use thereof in treating autoimmune diseases

#501
20230406847
2023-12-21

LIGANDS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) CONTAINING HETEROAROMATIC LINKER BUILDING BLOCKS

#502
20230399322
2023-12-14

EIF4E inhibitors and uses thereof

#503
20230391782
2023-12-07

INTERLEUKIN-17 INHIBITORS

#504
20230391774
2023-12-07

Novel Compounds

#505
20230391764
2023-12-07

BENZOTHIAZOLYL BICYCLO[1.1.1]PENTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#506
20230391723
2023-12-07

1,4-substituted piperidine derivatives

#507
20230382903
2023-11-30

SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF

#508
20230381150
2023-11-30

RILUZOLE PRODRUGS AND THEIR USE

#509
20230381149
2023-11-30

Riluzole prodrugs and their use

#510
20230373985
2023-11-23

KINASE MODULATORS AND METHODS OF USE THEREOF

#511
20230373935
2023-11-23

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#512
20230365566
2023-11-16

HETEROCYCLIC AMIDES AND THEIR USE FOR MODULATING SPLICING

#513
20230365533
2023-11-16

BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS

#514
20230365525
2023-11-16

Antiviral compounds

#515
20230365519
2023-11-16

CARBOXYLIC DIARYLTHIAZEPINEAMINES AND USES THEREOF

#516
20230365507
2023-11-16

INHIBITORS OF NLRP3 INFLAMMASOME

#517
20230357221
2023-11-09

Heterocyclic mitochondrial activity inhibitors and uses thereof

#518
20230357208
2023-11-09

MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS

#519
20230355590
2023-11-09

ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE

#520
20230348450
2023-11-02

CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE

#521
20230348448
2023-11-02

PYRAZOLE ACYLHYDRAZONE CONTAINING TRIFLUOROMETHYLTHIADIAZOLE UNITS, PREPARATION METHOD AND USE THEREOF

#522
20230348401
2023-11-02

Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof

#523
20230348384
2023-11-02

Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides

#524
20230339960
2023-10-26

Bicyclic-fused heteroaryl or aryl compounds

#525
20230339916
2023-10-26

PLANT GROWTH REGULATOR COMPOUNDS

#526
20230339890
2023-10-26

AMINO ALCOHOL COMPOUNDS AND USES THEREOF

#527
20230331715
2023-10-19

SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#528
20230322755
2023-10-12

CRYSTAL OF COMPOUND X7 HYDROCHLORIDE AND ITS PREPARATION METHOD AND APPLICATION

#529
20230322754
2023-10-12

IRAK INHIBITORS AND USES THEREOF

#530
20230322726
2023-10-12

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

#531
20230322695
2023-10-12

Inhibitors of protein tyrosine phosphatase, compositions, and methods of use

#532
20230322672
2023-10-12

COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES

#533
20230312580
2023-10-05

1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS

#534
20230312550
2023-10-05

N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides

#535
20230312548
2023-10-05

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#536
20230312544
2023-10-05

Compounds useful for inhibiting RET kinase

#537
20230312528
2023-10-05

2-OXO-IMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS

#538
20230312491
2023-10-05

N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#539
20230312490
2023-10-05

MCL-1 inhibitors

#540
20230312481
2023-10-05

SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF

#541
20230310373
2023-10-05

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#542
20230303552
2023-09-28

ARYLSULFONYL DERIVATIVES AND THEIR USE AS MUSCARINIC ACETYLCHOLINE RECEPTOR M5 INHIBITORS

#543
20230303544
2023-09-28

LMO2 PROTEIN INHIBITORS

#544
20230303522
2023-09-28

ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF

#545
20230303517
2023-09-28

DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES COMPOUNDS

#546
20230295180
2023-09-21

Protein degraders and uses thereof

#547
20230295149
2023-09-21

MONOBACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS

#548
20230295147
2023-09-21

Aryl hydrocarbon receptor (AHR) agonists and uses thereof

#549
20230287021
2023-09-14

COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING

#550
20230286968
2023-09-14

ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#551
20230286942
2023-09-14

NEW PqsR INVERSE AGONISTS

#552
20230286930
2023-09-14

N -SUBSTITUTED 4-(1,3-ARYLOXAZOLO-2-YL)PHENYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#553
20230286927
2023-09-14

2-PHENYLBENZOTRIAZOL-5-AMINE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS (HBV) INFECTION

#554
20230286925
2023-09-14

PHENYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR

#555
20230279008
2023-09-07

PTGR2 inhibitors and their use

#556
20230279007
2023-09-07

Compounds for Improving mRNA Splicing

#557
20230278997
2023-09-07

BICYCLO[1.1.1]PENTANE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#558
20230278969
2023-09-07

Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#559
20230278965
2023-09-07

NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF

#560
20230278957
2023-09-07

TREX1 INHIBITORS AND USES THEREOF

#561
20230277547
2023-09-07

Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

#562
20230276699
2023-08-31

Organic electric element

#563
20230271941
2023-08-31

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#564
20230265088
2023-08-24

Method of the preparation of fused multicyclic compounds

#565
20230265085
2023-08-24

RET kinase inhibitors

#566
20230265054
2023-08-24

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#567
20230257349
2023-08-17

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#568
20230250071
2023-08-10

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

#569
20230250060
2023-08-10

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#570
20230242548
2023-08-03

Compositions and methods for treating cancer

#571
20230242523
2023-08-03

Compound, tautomer of compound or salt of compound or tautomer, method for producing same, coloring composition, dyeing method, and dyed article

#572
20230242496
2023-08-03

SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA

#573
20230242494
2023-08-03

MALONITRILE DERIVATIVES

#574
20230234953
2023-07-27

IRAK DEGRADERS AND USES THEREOF

#575
20230234948
2023-07-27

CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS

#576
20230233560
2023-07-27

Modulators of cystic fibrosis transmembrane conductance regulator

#577
20230227484
2023-07-20

PYRIMIDINE COMPOUND AS AXL INHIBITOR

#578
20230227447
2023-07-20

BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS

#579
20230227445
2023-07-20

BENZAMIDE COMPOUND AND USE THEREOF

#580
20230227444
2023-07-20

BETA-LACTAM COMPOUND, USE THEREOF AND PREPARATION METHOD THEREFOR

#581
20230227441
2023-07-20

2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS

#582
20230227430
2023-07-20

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#583
20230227409
2023-07-20

QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

#584
20230227406
2023-07-20

MODULATORS OF E3 LIGASES

#585
20230227405
2023-07-20

5-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORS

#586
20230219967
2023-07-13

Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors

#587
20230219926
2023-07-13

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

#588
20230219925
2023-07-13

BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC COMPOUND AND APPLICATION THEREOF

#589
20230219908
2023-07-13

NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#590
20230219897
2023-07-13

Pyrazole MAGL inhibitors

#591
20230219896
2023-07-13

Cannabinoid receptor mediating compounds

#592
20230218612
2023-07-13

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE

#593
20230212157
2023-07-06

PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS

#594
20230212152
2023-07-06

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

#595
20230212131
2023-07-06

COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF

#596
20230203030
2023-06-29

Compounds and methods for the enhanced degradation of targeted proteins

#597
20230203026
2023-06-29

PESTICIDAL COMPOSITIONS AND METHODS

#598
20230203025
2023-06-29

ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A

#599
20230203024
2023-06-29

THIAZOLOXIME AND OXAZOLOXIME DERIVATIVES AS REACTIVATORS OF ORGANOPHOSPHOROUS NERVE AGENT (OPNA)-INHIBITED HUMAN ACETYLCHOLINESTERASE FOR THE TREATMENT OF NERVOUS AND/OR RESPIRATORY FAILURE AFTER INTOXICATION WITH OPNA

#600
20230203016
2023-06-29

DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES